{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:13:16Z","timestamp":1789441996222,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21H03197"],"award-info":[{"award-number":["JP21H03197"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hemodynamic stabilization is a core component in the resuscitation of septic shock. However, the optimal target blood pressure remains debatable. Previous randomized controlled trials suggested that uniformly adopting a target mean arterial pressure (MAP) higher than 65\u2009mmHg for all adult septic shock patients would not be beneficial; however, it has also been proposed that higher target MAP may be beneficial for elderly patients, especially those with arteriosclerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicenter, pragmatic single-blind randomized controlled trial will be conducted to compare target MAP of 80\u201385\u2009mmHg (high-target) and 65\u201370\u2009mmHg (control) in the resuscitation of septic shock patients admitted to 28 hospitals in Japan. Patients with septic shock aged \u226565\u2009years are randomly assigned to the high-target or control groups. The target MAP shall be maintained for 72\u2009h after randomization or until vasopressors are no longer needed to improve patients\u2019 condition. To minimize the adverse effects related to catecholamines, if norepinephrine dose of \u2265\u20090.1\u2009\u03bcg\/kg\/min is needed to maintain the target MAP, vasopressin will be initiated. Other therapeutic approaches, including fluid administration, hydrocortisone use, and antibiotic choice, will be determined by the physician in charge based on the latest clinical guidelines. The primary outcome is all-cause mortality at 90\u2009days after randomization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The result of this trial will provide great insight on the resuscitation strategy for septic shock in the era of global aged society. Also, it will provide the better understanding on the importance of individualized treatment strategy in hemodynamic management in critically ill patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>UMIN Clinical Trials Registry; UMIN000041775. Registered 13 September 2020.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-022-06732-9","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T13:02:53Z","timestamp":1664024573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Optimal target blood pressure in elderly with septic shock (OPTPRESS) trial: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5967-0776","authenticated-orcid":false,"given":"Akira","family":"Endo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Sera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikashi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kazuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Okura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todani","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yokokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Sageshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Otomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,24]]},"reference":[{"key":"6732_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","volume":"23","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. 2019;23:196.","journal-title":"Crit Care"},{"key":"6732_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"6732_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1164\/rccm.202004-1124ED","volume":"202","author":"JA Russell","year":"2020","unstructured":"Russell JA. Personalized blood pressure targets in shock: what if your normal blood pressure is \u201clow\u201d? Am J Respir Crit Care Med. 2020;202:10\u20132.","journal-title":"Am J Respir Crit Care Med"},{"key":"6732_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13054-015-0794-z","volume":"19","author":"M Leone","year":"2015","unstructured":"Leone M, Asfar P, Radermacher P, Vincent JL, Martin C. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature. Crit Care. 2015;19:101.","journal-title":"Crit Care"},{"key":"6732_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13054-015-0958-x","volume":"19","author":"TD Corr\u00eaa","year":"2015","unstructured":"Corr\u00eaa TD, Jakob SM, Takala J. Arterial blood pressure targets in septic shock: is it time to move to an individualized approach? Crit Care. 2015;19:264.","journal-title":"Crit Care"},{"key":"6732_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/CCM.0000000000003795","volume":"47","author":"KT Fiorese Coimbra","year":"2019","unstructured":"Fiorese Coimbra KT, de Freitas FGR, Bafi AT, Pinheiro TT, Nunes NF, de Azevedo LCP, et al. Effect of increasing blood pressure with noradrenaline on the microcirculation of patients with septic shock and previous arterial hypertension. Crit Care Med. 2019;47:1033\u201340.","journal-title":"Crit Care Med"},{"key":"6732_CR7","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","volume":"370","author":"P Asfar","year":"2014","unstructured":"Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583\u201393.","journal-title":"N Engl J Med"},{"key":"6732_CR8","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00134-016-4237-3","volume":"42","author":"F Lamontagne","year":"2016","unstructured":"Lamontagne F, Meade MO, H\u00e9bert PC, Asfar P, Lauzier F, Seely AJE, et al. Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med. 2016;42:542\u201350.","journal-title":"Intensive Care Med"},{"key":"6732_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00134-016-4249-z","volume":"42","author":"DT Andreis","year":"2016","unstructured":"Andreis DT, Singer M. Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med. 2016;42:1387\u201397.","journal-title":"Intensive Care Med"},{"key":"6732_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1164\/rccm.202002-0339OC","volume":"202","author":"RF Stolk","year":"2020","unstructured":"Stolk RF, van der Pasch E, Naumann F, Schouwstra J, Bressers S, van Herwaarden AE, et al. Norepinephrine dysregulates the immune response and compromises host defense during Sepsis. Am J Respir Crit Care Med. 2020;202:830\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"6732_CR11","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jama.2020.0930","volume":"323","author":"F Lamontagne","year":"2020","unstructured":"Lamontagne F, Richards-Belle A, Thomas K, Harrison DA, Sadique MZ, Grieve RD, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA. 2020;323:938\u201349.","journal-title":"JAMA"},{"key":"6732_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","volume":"360","author":"D Brealey","year":"2002","unstructured":"Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360:219\u201323.","journal-title":"Lancet"},{"key":"6732_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/MCC.0000000000000241","volume":"21","author":"EP Rivers","year":"2015","unstructured":"Rivers EP, Yataco AC, Jaehne AK, Gill J, Disselkamp M. Oxygen extraction and perfusion markers in severe sepsis and septic shock: diagnostic, therapeutic and outcome implications. Curr Opin Crit Care. 2015;21:381\u20137.","journal-title":"Curr Opin Crit Care"},{"key":"6732_CR14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1001\/jama.2017.14172","volume":"318","author":"E Futier","year":"2017","unstructured":"Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318:1346\u201357.","journal-title":"JAMA"},{"key":"6732_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13054-021-03813-0","volume":"25","author":"JL Vincent","year":"2021","unstructured":"Vincent JL, Singer M, Einav S, Moreno R, Wendon J, Teboul JL, et al. Equilibrating SSC guidelines with individualized care. Crit Care. 2021;25:397.","journal-title":"Crit Care"},{"key":"6732_CR16","unstructured":"Japanese Ministry of Health Labour and Welfare: Result of National health and nutrition examination survey. https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&toukei=00450171&tstat=000001041744. Accessed 6 Sept 2022."},{"key":"6732_CR17","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1016\/S2214-109X(18)30259-6","volume":"6","author":"T Beaney","year":"2018","unstructured":"Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, et al. May measurement month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6:e736\u201343.","journal-title":"Lancet Glob Health"},{"key":"6732_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"6732_CR19","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00134-016-4500-7","volume":"42","author":"PB Hjortrup","year":"2016","unstructured":"Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettil\u00e4 V, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the classic randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42:1695\u2013705.","journal-title":"Intensive Care Med"},{"key":"6732_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/CCM.0000000000002189","volume":"45","author":"Y Sakr","year":"2017","unstructured":"Sakr Y, Rubatto Birri PN, Kotfis K, Nanchal R, Shah B, Kluge S, et al. Higher fluid balance increases the risk of death from sepsis: results from a large international audit. Crit Care Med. 2017;45:386\u201394.","journal-title":"Crit Care Med"},{"key":"6732_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00134-017-5016-5","volume":"44","author":"F Lamontagne","year":"2018","unstructured":"Lamontagne F, Day AG, Meade MO, Cook DJ, Guyatt GH, Hylands M, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med. 2018;44:12\u201321.","journal-title":"Intensive Care Med"},{"key":"6732_CR22","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, H\u00e9bert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877\u201387.","journal-title":"N Engl J Med"},{"key":"6732_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509\u201318.","journal-title":"JAMA"},{"key":"6732_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40560-021-00555-7","volume":"9","author":"M Egi","year":"2021","unstructured":"Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020). J Intensive Care. 2021;9:53.","journal-title":"J Intensive Care"},{"key":"6732_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","volume":"24","author":"M Bauer","year":"2020","unstructured":"Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019\u2014results from a systematic review and meta-analysis. Crit Care. 2020;24:239.","journal-title":"Crit Care"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06732-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06732-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06732-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T13:17:34Z","timestamp":1664025454000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06732-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6732"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06732-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,24]]},"assertion":[{"value":"6 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical trial will be conducted according to the principles of the Declaration of Helsinki (revised October 2013) and the Ethical Guidelines for Medical and Health Research Involving Human Subjects published by the Ministry of Health, Labour and Welfare of Japan and the Japanese Ministry of Education, Culture, Sports, Science, and Technology. The study protocol has been approved by the Ethics Committee of the principal hospital (approval number: R2020\u2013015) and each participating hospital. If any modification in the trial protocol will be made, principal investigator will immediately communicate those to the responsible person at the participating hospital, the Ethics Committee of the principal hospital, the safety monitoring committee, and the data monitoring committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0{24}"}},{"value":"There are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0{32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0{28}"}}],"article-number":"799"}}